Medtronic Reports Three-Year Data Confirming Durab...
Category : Clinical Trial Update 27 October 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced final results from th...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
UCB Reports Three-Year Data Showing Sustained Effi...
Category : Clinical Trial Update 27 October 2025UCB, a global biopharmaceutical company, announced new three-year data from its Phase 3 trials and t...
Secarna Pharmaceuticals and Scenic Biotech Join Fo...
Category : Licensing/Collaboration Deal 27 October 2025Secarna Pharmaceuticals GmbH & Co. KG, a biotechnology company focused on next-generation oligon...
Neurotronic to Present First Clinical Outcomes for...
Category : Clinical Trial Update 25 October 2025Neurotronic, Inc., a U.S.-based medical technology company developing multi-organ denervation therap...
Johnson & Johnson Reports Positive Phase 2 Results...
Category : Clinical Trial Update 25 October 2025Johnson & Johnson (NYSE: JNJ) announced that nipocalimab, its first-in-class FcRn inhibitor, met...
Latest Newsletter Post
-
Secarna Pharmaceuticals and Scenic..
27 October 2025
-
UCB Reports Three-Year Data Showing..
27 October 2025
-
Medtronic Reports Three-Year Data C..
27 October 2025
-
Halia Therapeutics Receives FDA Orp..
25 October 2025
-
Johnson & Johnson Reports Positive..
25 October 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com